| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Robarts Research Institute and Department of Medicine (R.A.H., J.W., H.C.), and the Center for Studies in Family Medicine (S.B.H.), University of Western Ontario, London, Ontario, Canada N6A 5K8; and the Samuel Lunenfeld Research Institute and Department of Medicine, Mount Sinai Hospital (B.Z., A.J.G.H.), and the Department of Genetics, The Hospital for Sick Children, University of Toronto (L.-C.T., S.W.S.), Toronto, Ontario, Canada M5G 1X8
Address all correspondence and requests for reprints to: Robert A. Hegele, M.D., Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406100 Perth Drive, London, Ontario, Canada N6A 5K8. E-mail: robert.hegele{at}rri.on.ca
We are investigating associations between variations in candidate genes on chromosome 7q and diabetes-related phenotypes in Canadian Oji-Cree. One of these genes encodes the skeletal muscle regulatory G subunit of the glycogen-associated form of protein phosphatase 1 (PPPIR3), which may play a key role in muscle glycogen metabolism. There is a common 5-bp insertion-deletion polymorphism in a messenger ribonucleic acid-stabilizing AU(AT)-rich element within the 3'-untranslated region (UTR) of PPPIR3. The D allele had a frequency of 0.30 in the Oji-Cree. We found that this 3'-UTR variation of PPPIR3 was significantly associated with variation in 2-h postprandial glucose in adult Oji-Cree with type 2 diabetes or impaired glucose tolerance (IGT). Specifically, Oji-Cree with diabetes or IGT who were D/D homozygotes had significantly lower 2-h postprandial plasma glucose than subjects with the other genotypes. There was no association of the PPPIR3 genotype either with the presence of type 2 diabetes or IGT or with other quantitative traits in this sample. These findings suggest that common PPPIR3 3'-UTR variation that potentially affects messenger ribonucleic acid stability is associated with variation in glycemia in Oji-Cree subjects with type 2 diabetes.
This article has been cited by other articles:
![]() |
P. An, B. I. Freedman, S. S. Rich, S. A. Mandel, D. K. Arnett, R. H. Myers, Y.-D. I. Chen, S. C. Hunt, and D.C. Rao Quantitative Trait Loci on Chromosome 8q24 for Pancreatic {beta}-Cell Function and 7q11 for Insulin Sensitivity in Obese Nondiabetic White and Black Families: Evidence From Genome-Wide Linkage Scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) Study Diabetes, February 1, 2006; 55(2): 551 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Alcoser, M. Hara, G. I. Bell, and D. A. Ehrmann Association of the (AU)AT-Rich Element Polymorphism in PPP1R3 with Hormonal and Metabolic Features of Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2973 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delibegovic, C. G. Armstrong, L. Dobbie, P. W. Watt, A. J.H. Smith, and P. T.W. Cohen Disruption of the Striated Muscle Glycogen Targeting Subunit PPP1R3A of Protein Phosphatase 1 Leads to Increased Weight Gain, Fat Deposition, and Development of Insulin Resistance Diabetes, March 1, 2003; 52(3): 596 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Liolitsa, J Powell, and S Lovestone Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, September 1, 2002; 73(3): 261 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Elbein Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era Endocrinology, June 1, 2002; 143(6): 2012 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deakin, I. Leviev, V. Nicaud, M.-C. B. Meynet, L. Tiret, and R. W. James Paraoxonase-1 L55M Polymorphism Is Associated with an Abnormal Oral Glucose Tolerance Test and Differentiates High Risk Coronary Disease Families J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1268 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Elbein, W. Chu, Q. Ren, C. Hemphill, J. Schay, N. J. Cox, C. L. Hanis, and S. J. Hasstedt Role of Calpain-10 Gene Variants in Familial Type 2 Diabetes in Caucasians J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 650 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mok, H. Cao, B. Zinman, A. J. G. Hanley, S. B. Harris, B. P. Kennedy, and R. A. Hegele A Single Nucleotide Polymorphism in Protein Tyrosine Phosphatase PTP-1B Is Associated with Protection from Diabetes or Impaired Glucose Tolerance in Oji-Cree J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 724 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Young, J. Reading, B. Elias, and J. D. O'Neil Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress Can. Med. Assoc. J., September 1, 2000; 163(5): 561 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Hegele, C. M. Anderson, J. Wang, D. C. Jones, and H. Cao Association Between Nuclear Lamin A/C R482Q Mutation and Partial Lipodystrophy with Hyperinsulinemia, Dyslipidemia, Hypertension, and Diabetes Genome Res., May 1, 2000; 10(5): 652 - 658. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |